Literature DB >> 23902431

A randomized, double-blind, placebo-controlled clinical trial to investigate the effect of Cynatine(®) HNS on skin characteristics.

C Beer1, S Wood, R H Veghte.   

Abstract

OBJECTIVE: A new, novel product, Cynatine(®) HNS was evaluated for its effects as a supplement for improving various aspects of skin in a randomized, double-blind, placebo-controlled clinical trial.
METHODS: A total of 50 females were included and randomized into two groups. The active group (n = 25) received two capsules totalling of Cynatine(®) HNS, comprised of Cynatine(®) brand keratin (500 mg) plus vitamins and minerals, per day, and the placebo group (n = 25) received two identical capsules of maltodextrin per day for 90 days. End points for skin moisture, skin elasticity, wrinkle reduction, skin compactness and skin appearance were measured.
RESULTS: The results show that subjects taking Cynatine(®) HNS showed statistically significant improvements in their skin when compared with placebo.
CONCLUSION: Cynatine(®) HNS is an effective supplement for improving skin in 90 days or less.
© 2013 Society of Cosmetic Scientists and the Société Française de Cosmétologie.

Entities:  

Keywords:  Cynatine® HNS; healthy skin; reduced wrinkles; skin elasticity; skin moisture

Mesh:

Substances:

Year:  2013        PMID: 23902431     DOI: 10.1111/ics.12084

Source DB:  PubMed          Journal:  Int J Cosmet Sci        ISSN: 0142-5463            Impact factor:   2.970


  1 in total

1.  A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating an Oral Anti-aging Skin Care Supplement for Treating Photodamaged Skin.

Authors:  Thomas J Stephens; Monya L Sigler; Peter D Hino; Anne Le Moigne; Lisa Dispensa
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.